Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
about
P1343
IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearanceRecruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartmentInterferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV)Linking metabolism and epigenetic regulation in development of hepatocellular carcinomaIntragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell deathHepatitis C Virus Infection Induces Apoptosis through a Bax-Triggered, Mitochondrion-Mediated, Caspase 3-Dependent PathwayGenomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured HepatocytesUsing high-throughput genomics to study hepatitis C: What determines the outcome of infection?Hepatitis C virus replicons: dinosaurs still in business?Mouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell LineHepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant HepatocytesTargeted delivery of chemotherapy agents using a liver cancer-specific aptamer2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinaseTRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implicationsLong-term effect on natural killer cells by interferon-α therapy on the outcomes of HCV infection.Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerCharacterization of HCV interactions with Toll-like receptors and RIG-I in liver cells.Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV)Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells.Innate host response in primary human hepatocytes with hepatitis C virus infectionTRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT.TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients.Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation.Role of Hepatitis C virus core protein in viral-induced mitochondrial dysfunction.Hepatitis C virus sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1-dependent pathwayCharacterization of Anti-HCV Antibodies in IL-10-Treated PatientsActivation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro.The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1.HIV infection increases HCV-induced hepatocyte apoptosis.DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma.Coinfection with HIV-1 and HCV--a one-two punch.The TRAIL to viral pathogenesis: the good, the bad and the uglyMiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12aHepatitis C virus and antiviral innate immunity: who wins at tug-of-war?Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication.EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV InfectionCyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinomaHepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases.HMGB1 Promotes Hepatitis C Virus Replication by Interaction with Stem-Loop 4 in the Viral 5' Untranslated Region.
P2860
Q22121973-98A26D7F-1BFB-45F1-BEB4-3ABA7EFAD92CQ24337128-DBFC3B99-7691-4354-8F3E-2663266E7DC8Q26778005-6DD717DB-8FBE-428B-815E-1DEB32D1675EQ27023744-15AC5CA0-A523-4C68-A5E4-8242177F7EB9Q27486571-08767BC2-376D-46B7-9E16-6DCB046A690BQ27487135-C13CD11C-6803-4EA6-89AF-E5D61303DCFFQ27487541-8D62DE07-8F39-4A55-AF18-6A9E8F732EDEQ27488407-67CD1171-9A40-4144-9FDD-746069664BB0Q27488905-141F81AE-55A4-4AAF-9B2B-57D9C7F83CBAQ27490526-3700F13E-0D35-4FA8-ACD7-91592A0FEC47Q27490901-029914CD-CB23-483E-987C-92221DBCEAD3Q28482911-5B3E6BBE-5359-49AA-9FF4-7FCDED488528Q28533471-BC8F08F9-C122-4F3E-AC2A-A44E06170334Q28539681-65EA205A-37C4-4DF9-BC4C-6F6D339B6128Q33588171-4D90FC23-CCFA-4B56-82AF-C59CF318029AQ33822643-016E4DE7-79FE-4AAA-958A-B373DFC36B60Q33939184-26888C36-DA0A-4128-BAC1-C4A5C6FC9177Q33952278-6AC230F3-33C9-4418-B9D4-D361724F9BF6Q33988315-5CCE7401-CF36-47FD-B959-D739A25ECDFFQ34075737-5C374862-F179-4D09-8E38-E6C55A0DE9DFQ34081462-703C8D5B-16E7-43E5-AD7B-C47B6B61F88DQ34104106-228E79B6-76DF-405C-A2B0-5C33EB519A22Q34188474-126BDA27-EC9D-46D4-B548-1102538F9B2FQ34229606-EF34C0B5-321A-41F3-B99C-EC78AA40ED66Q34267922-2DDC6EDA-D7C6-410C-8979-C9718E22C3B0Q34291165-335F3985-D946-4F23-B724-18879116E9AAQ34296870-61DABDC4-3B04-42B4-834C-FEA1C6F6E620Q34428880-11475E31-07DC-43A4-936A-0A269B10A3EBQ34655404-69798F56-680C-4ABA-8A05-1299EAE0D7F5Q34699457-1658EFEE-AE0D-4677-B3CF-227F261440A3Q34756569-96DE6AB2-1798-4116-884A-8956C9277F6FQ35137038-2224F20D-379F-444C-AE71-F336D5F66C93Q35146349-5E9D4F2C-3616-4202-A387-B53BB218115BQ35146636-6782C658-2FEE-4405-BD82-620FD7DECD38Q35270150-5F71D724-7770-4386-B3CA-9C19D2C51F3EQ35489968-5CBF1FA7-1B26-44A8-951F-43D4963B28D2Q35749502-3D089D53-A2C4-4483-980D-5BAAA33EF87CQ35783090-9631908F-6285-4D27-BDA5-E7F6CD3E1D19Q36395865-DC3B61B4-33BA-4CF9-88B5-7DEBBFDB15F8Q36736824-189FE91F-11D0-4AD8-99C5-4B77AA811B3F
P2860
Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hepatitis C virus triggers apo ...... ough antiviral defense system.
@en
type
label
Hepatitis C virus triggers apo ...... ough antiviral defense system.
@en
prefLabel
Hepatitis C virus triggers apo ...... ough antiviral defense system.
@en
P2093
P1433
P1476
Hepatitis C virus triggers apo ...... rough antiviral defense system
@en
P2093
Alan Hemming
David R Nelson
Haizhen Zhu
Huijia Dong
James M Crawford
Mengde Cao
P304
P356
10.1053/J.GASTRO.2007.09.017
P407
P4510
P577
2007-09-16T00:00:00Z